[PHARMA] QoQ Quarter Result on 30-Sep-2024 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
26-Nov-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
30-Sep-2024 [#3]
Profit Trend
QoQ- 3512.16%
YoY- 304.77%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 1,029,822 838,256 964,959 789,807 885,486 848,734 880,454 10.98%
PBT 138,485 3,334 39,044 -22,099 -56,259 6,342 9,193 506.94%
Tax -37,166 512 -12,865 -9,980 7,212 -4,018 -6,427 221.14%
NP 101,319 3,846 26,179 -32,079 -49,047 2,324 2,766 995.74%
-
NP to SH 101,032 2,797 25,646 -32,721 -49,339 1,961 2,648 1025.84%
-
Tax Rate 26.84% -15.36% 32.95% - - 63.36% 69.91% -
Total Cost 928,503 834,410 938,780 821,886 934,533 846,410 877,688 3.81%
-
Net Worth -174,968 -272,968 -272,392 -281,734 -245,740 -137,571 -142,812 14.45%
Dividend
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Div - - - - - - - -
Div Payout % - - - - - - - -
Equity
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Net Worth -174,968 -272,968 -272,392 -281,734 -245,740 -137,571 -142,812 14.45%
NOSH 1,441,255 1,441,229 1,441,229 1,441,229 1,441,229 1,310,208 1,310,208 6.54%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 9.84% 0.46% 2.71% -4.06% -5.54% 0.27% 0.31% -
ROE 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 71.45 58.16 66.95 57.75 65.94 64.78 67.20 4.16%
EPS 7.01 0.19 1.78 -2.39 -3.67 0.15 0.20 964.09%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
NAPS -0.1214 -0.1894 -0.189 -0.206 -0.183 -0.105 -0.109 7.42%
Adjusted Per Share Value based on latest NOSH - 1,441,255
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 71.45 58.16 66.95 54.80 61.44 58.89 61.09 10.97%
EPS 7.01 0.19 1.78 -2.27 -3.42 0.14 0.18 1041.30%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
NAPS -0.1214 -0.1894 -0.189 -0.1955 -0.1705 -0.0955 -0.0991 14.44%
Price Multiplier on Financial Quarter End Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 30/09/24 28/06/24 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 -
Price 0.39 0.37 0.355 0.385 0.435 0.37 0.285 -
P/RPS 0.55 0.64 0.53 0.67 0.66 0.57 0.42 19.63%
P/EPS 5.56 190.65 19.95 -16.09 -11.84 247.21 141.02 -88.34%
EY 17.97 0.52 5.01 -6.21 -8.45 0.40 0.71 756.97%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
P/NAPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Price Multiplier on Announcement Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 26/11/24 21/08/24 27/05/24 29/02/24 29/11/23 11/08/23 18/05/23 -
Price 0.355 0.43 0.39 0.37 0.405 0.42 0.38 -
P/RPS 0.50 0.74 0.58 0.64 0.61 0.65 0.57 -8.34%
P/EPS 5.06 221.57 21.92 -15.46 -11.02 280.62 188.02 -90.96%
EY 19.75 0.45 4.56 -6.47 -9.07 0.36 0.53 1008.32%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
P/NAPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment